Clinical Trial Update: A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function [Phase 4]

View source ↗

Summary

A completed Phase 4 randomized, double-blind study comparing the safety and antiviral activity of 48 weeks of clevudine versus adefovir dipivoxil in HBeAg-negat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)
• Clevudine (clevudine)

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: HBeAg(-) Chronic Hepatitis B With Compensated Liver Function | Phase 4 | Status: COMPLETED